Roberto Cauda
← Back to Università Cattolica del Sacro Cuore
Università Cattolica del Sacro Cuore
Roberto Cauda works in HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, Antibiotic Use and Resistance. Recorded institutional associations include Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 · 1,268 citationsPredictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
2012 · 1,016 citationsNew insights into the antiviral effects of chloroquine
2006 · 570 citationsInfections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study
2015 · 511 citationsEffect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
1996 · 495 citationsPredictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment
2007 · 461 citationsDoes antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis
2007 · 435 citationsRemdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
2022 · 394 citationsEfficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae
2018 · 354 citationsBiofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia
2007 · 341 citationsBloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical Outcome
2006 · 283 citationsCeftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
2021 · 275 citationsRisk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study
2014 · 267 citationsEvolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy
2020 · 255 citationsEfavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
2011 · 242 citationsCosts of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy
2010 · 224 citationsUsefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)
2002 · 214 citationsImproving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial
2006 · 214 citationsIn Vitro and In Vivo Anticandidal Activity of Human Immunodeficiency Virus Protease Inhibitors
1999 · 210 citationsBetter response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
2001 · 206 citationsBenefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital Stay
2006 · 199 citationsRisk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital
2012 · 197 citationsIncidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
2009 · 194 citationsRisk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
2015 · 193 citationsCommon cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study
2020 · 184 citations
